BCG treatment of residual disease in acute leukemia: Studies in a rat model for human acute myelocytic leukemia (BNML)
- 1 January 1983
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 7 (4) , 547-555
- https://doi.org/10.1016/0145-2126(83)90049-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The role of bone marrow transplantation in the treatment of acute leukemia in remissionBlood, 1982
- Treatment of acute myelogenous leukemia: Influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapyCancer, 1982
- In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration.The Journal of Experimental Medicine, 1982
- The effect of fractionated versus unfractionated total body irradiation on the growth of the bn acute myelocytic leukemiaInternational Journal of Radiation Oncology*Biology*Physics, 1981
- The relevance of cell kinetics for optimal scheduling of 1-?-d-Arabinofuranosyl cytosine and methotrexate in a slow growing acute myeloid leukemia (BNML)Cancer Chemotherapy and Pharmacology, 1978
- Proliferation kinetics of the BNML leukaemia in vivoLeukemia Research, 1977
- Introduction of the BN myelocytic leukaemiaLeukemia Research, 1977
- BCG in the treatment of acute lymphocytic leukemiaBlood, 1975
- Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.British Journal of Cancer, 1969
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969